Belen Garijo MD, PhD

Belen Garijo, born on July 31, 1960 in Almansa, Spain, has been a member of the Executive Board of Merck since January 2015 as CEO of the Healthcare business sector. She additionally assumed Executive Board responsibility for Group Human Resources in September 2017 and for Environment, Health, Safety, Security, Quality (EQ) in October 2018. Since 2013, she has also served as President and CEO of the Biopharma business, where she joined Merck in 2011 as Chief Operating Officer.

Before joining Merck, Belen Garijo served as the Senior Vice President Global Operations Europe at Sanofi-Aventis, where she was also a member of the Management Committee of the Sanofi-Aventis Group and of the Management Board of the Sanofi-Pasteur vaccines joint venture with MSD. In 2011, she took on the additional role of Global Integration Leader for the Genzyme acquisition.